1,092
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

A longitudinal study of restless legs symptoms among patients with depression

ORCID Icon, , , , , & show all
Pages 584-590 | Received 20 Jun 2021, Accepted 17 Jan 2022, Published online: 22 Feb 2022

References

  • Miner B, Gill TM, Yaggi HK, et al. Insomnia in Community-Living persons with advanced age. J Am Geriatr Soc. 2018;66(8):1592–1597.
  • Fawale MB, Ismail IA, Mustapha AF, et al. Restless legs syndrome in a nigerian elderly population. J Clin Sleep Med. 2016;12(07):965–972.
  • Li Y, Li Y, Winkelman JW, et al. Prospective study of restless legs syndrome and total and cardiovascular mortality among women. Neurology. 2018;90(2):e135–e141.
  • Zhuang S, Na M, Winkelman JW, et al. Association of restless legs syndrome with risk of suicide and Self-harm. JAMA Netw Open. 2019;2(8):e199966.
  • Li Y, Wang W, Winkelman JW, et al. Prospective study of restless legs syndrome and mortality among men. Neurology. 2013;81(1):52–59.
  • Cho YW, Kim DH, Allen RP, et al. Assessing health-related quality of life in patients with restless legs syndrome in Korea: comparison with other chronic medical diseases. Sleep Med. 2012;13(9):1158–1163.
  • Mackie S, Winkelman JW. Restless legs syndrome and psychiatric disorders. Sleep Med Clin. 2015;10(3):351–357,
  • Becker PM, Sharon D. Mood disorders in restless legs syndrome (Willis-Ekbom disease). J Clin Psychiatry. 2014;75(7):679.
  • Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894–902.
  • Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med. 2001;10(4):335–341.
  • Allen RP, Picchietti DL, Garcia-Borreguero D, International Restless Legs Syndrome Study Group, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria-history, rationale, description, and significance. Sleep Med. 2014;15(8):860–873.
  • Auvinen P, Mäntyselkä P, Koponen H, et al. Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients. J Psychosom Res. 2018;115:1–5.
  • Salminen AV, Rimpila V, Polo O. Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease). Neurology. 2014;82(21):1856–1861.
  • Garcia-Borreguero D, Larrosa O, Granizo JJ, et al. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27(4):669–673.
  • Li Y, Mirzaei F, O'Reilly EJ, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol. 2012;176(4):279–288.
  • Szentkiralyi A, Volzke H, Hoffmann W, et al. The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. Psychosom Med. 2013; 75(4):359–365.
  • Wesström J, Skalkidou A, Manconi M, et al. Sundström-Poromaa I. Pre-pregnancy restless legs syndrome (Willis-Ekbom disease) is associated with perinatal depression. J Clin Sleep Med. 2014; 10(5):527–533.
  • Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20(1):101–105.
  • Auvinen P, Mäntyselkä P, Koponen H, et al. Prevalence of restless legs symptoms according to depressive symptoms and depression type: a cross-sectional study. Nord J Psychiatry. 2018;72(1):51–56.
  • Beck AT. A systematic investigation of depression. Compr Psychiatry. 1961;2(3):163–170.
  • Sheehan DV, Lecrubier Y, Janavs J. Mini-International neuropsychiatric interview (MINI). Tampa, FL, University of South Florida. Institute for Research in Psychiatry. 1994.
  • Koponen H, Kautiainen H, Leppänen E, et al. Cardiometabolic risk factors in patients referred to depression nurse case managers. Nord J Psychiatry. 2015; 69(4):262–267.
  • Ferri R, Lanuzza B, Cosentino FII, et al. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol. 2007;14(9):1016–1021.
  • Raatikainen I, Vanhala M, Mäntyselkä P, et al. Does level of leisure time physical activity, in a sample of patients with depression, predict health care utilization over a subsequent 5-year period? Findings from a finnish cohort study. Mental Health and Physical Activity. 2018;15:40–44.
  • Fuhs A, Bentama D, Antkowiak R, et al. Effects of short- and long-term variations in RLS severity on perceived health status - the COR-study. PLoS One. 2014;9(4):e94821.
  • Lee CS, Kim T, Lee S, et al. Symptom severity of restless legs syndrome predicts its clinical course. Am J Med. 2016;129(4):438–445.
  • During EH, Winkelman JW. Drug treatment of restless legs syndrome in older adults. Drugs Aging. 2019;36(10):939–946.
  • Baughman KR, Bourguet CC, Ober SK. Gender differences in the association between antidepressant use and restless legs syndrome. Mov Disord. 2009;24(7):1054–1059.
  • Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008;43(1):70–75.
  • Bailey AL, Makela EH, Asberg K. Selective serotonin reuptake inhibitor/Serotonin-Norepinephrine reuptake inhibitor use as a predictor of a diagnosis of restless legs syndrome. J Psychiatr Pract. 2016;22(4):263–269.
  • Kolla BP, Mansukhani MP, Bostwick JM. The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review. Sleep Med Rev. 2018;38:131–140. 04
  • Zhang C, Li Y, Malhotra A, et al. Restless legs syndrome status as a predictor for lower physical function. Neurology. 2014;82(14):1212–1218.
  • Batool-Anwar S, Li Y, De Vito K, et al. Lifestyle factors and risk of restless legs syndrome: Prospective cohort study. J Clin Sleep Med. 2016;12(02):187–194.
  • Carter JD, Assari S. Sustained obesity and depressive symptoms over 6 years: Race by gender differences in the health and retirement study. Front Aging Neurosci. 2016;8:312.
  • Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat Rev Rheumatol. 2015;11(2):86–97.
  • Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2003;19(8):751–760.